Women’s Health

Risks pf BSGI and PEM studies

According to a study in Radiology, a single breast-specific gamma imaging (BSGI) or positron emission mammography (PEM) test is “associated with a fatal radiation-induced…

FDA approves new drug for osteoporosis

On June 1, the U.S. Food and Drug Administration (FDA) approved Prolia (denosumab), an injectable treatment for postmenopausal women with osteoporosis who are at…

Risks pf BSGI and PEM studies

According to a study in Radiology, a single breast-specific gamma imaging (BSGI) or positron emission mammography (PEM) test is “associated with a…

FDA approves new drug for osteoporosis

On June 1, the U.S. Food and Drug Administration (FDA) approved Prolia (denosumab), an injectable treatment for postmenopausal women with osteoporosis who…

Poll

How confident are you using AI safely in practice?

Julie NyhusGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • This field is hidden when viewing the form

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.